Biotech and life sciences occupiers in San Francisco typically cluster in Financial District, plan ~320 sqft per seat at high-end fit-out ($235–330/sqft), and pay around 78 USD/sqft ($78 USD) on Class A.
Biotech and life sciences occupiers in San Francisco typically cluster in Financial District, plan ~320 sqft per seat at high-end fit-out">fit-out ($235–330/sqft), and pay around 78 USD/sqft ($78 USD) on Class A.
Biotech and life sciences occupiers in San Francisco typically anchor in Financial District. Banking, asset managers, law firms, professional services.
Class A rent in San Francisco runs 78 USD/sqft ($78 USD) on a 7-year lease with 22 months free. Prime submarkets sit at or modestly above the city index.
Typical biotech and life sciences fit-out targets high-end specification at $235–330/sqft. Branded reception, full client-facing programming, premium furniture, and specialist AV are standard.
Plan around 320 sqft per seat blended (workstation + circulation + amenity). A 100-headcount biotech office in San Francisco typically targets 32,000 sqft of leasable area.
Cluster effects are decisive: PhD-grade talent concentrates near academic-medical anchors and translational research institutes. Deepest AI/ML and senior software engineering talent pool globally. Average all-in compensation indexes 98 vs. New York's 100.
Headline corporate tax: 27%. Modified-gross with operating-expense escalations over a base year. Rent-free of 18-30 months on a 10-year term is current market for trophy assets in lease-up. TI of $150-$220/sqft is achievable. Termination options at year 5 are increasingly negotiable.
| city | San Francisco |
|---|---|
| industry | Biotech and life sciences |
| naics | 541714, 541715, 325412 |
| preferredSubmarket | Financial District |
| preferredFitoutSpec | High-end |
| fitoutBand | $235–330/sqft |
| sqftPerSeat | 320 |
| classARentLocal | 78 USD/sqft/yr |
| classARentUsd | $78/sqft/yr |
| vacancyPct | 31.5% |
| typicalLeaseYears | 7 |
| typicalRentFreeMonths | 22 |
| talentIndex | 98 |
| corporateTaxPct | 27% |
Reviewed by Miriam Hollander — Lead market analyst. Last updated 2026-04-15. See our methodology and editorial standards.